Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling.
J Immunol Res
; 2022: 5211368, 2022.
Article
in En
| MEDLINE
| ID: mdl-36254198
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Saponins
/
Phosphatidylinositol 3-Kinases
Limits:
Animals
Language:
En
Journal:
J Immunol Res
Year:
2022
Type:
Article
Affiliation country:
China